Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study
暂无分享,去创建一个
S. Bhatt | S. Flaxman | N. Grassly | Swapnil Mishra | H. Unwin | T. Mellan | H. Coupland | C. Whittaker | K. Ainslie | M. Baguelin | A. Boonyasiri | L. Cattarino | G. Cuomo-Dannenburg | A. Dighe | R. FitzJohn | K. Gaythorpe | W. Green | A. Hamlet | W. Hinsley | E. Knock | D. Laydon | P. Nouvellet | H. Thompson | E. Volz | C. Walters | O. Watson | C. Donnelly | L. Okell | M. Vollmer | N. Ferguson | N. Imai | Z. Cucunubá | G. Nedjati-Gilani | S. V. van Elsland | Yuanrong Wang | X. Xi | P. White | N. Brazeau | K. Fraser | L. Whittles | M. Pons-Salort | M. Ragonnet-Cronin | E. Parker | Kylie Marc Samir Adhiratha Nick Lorenzo Helen Zulma Gina Ainslie Baguelin Bhatt Boonyasiri Brazeau C
[1] E. Vynnycky,et al. The impact of testing and infection prevention and control strategies on within-hospital transmission dynamics of COVID-19 in English hospitals , 2020, Philosophical Transactions of the Royal Society B.
[2] Sarah K. Helman,et al. Quantifying antibody kinetics and RNA detection during early-phase SARS-CoV-2 infection by time since symptom onset , 2020, eLife.
[3] Ganna Rozhnova,et al. Impact of delays on effectiveness of contact tracing strategies for COVID-19: a modelling study , 2020, The Lancet Public Health.
[4] D. O’Neill,et al. Asymptomatic carriage rates and case-fatality of SARS-CoV-2 infection in residents and staff in Irish nursing homes , 2020, medRxiv.
[5] S. Bhatt,et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe , 2020, Nature.
[6] E. Lau,et al. Evolution of effective serial interval of SARS-CoV-2 by non-pharmaceutical interventions , 2020, Research square.
[7] F. Yu,et al. Serology characteristics of SARS-CoV-2 infection since exposure and post symptom onset , 2020, European Respiratory Journal.
[8] M. Drayson,et al. SARS-CoV-2 seroconversion in health care workers , 2020, medRxiv.
[9] Sarah K. Helman,et al. Quantifying antibody kinetics and RNA shedding during early-phase SARS-CoV-2 infection , 2020, medRxiv.
[10] M. E. Kretzschmar,et al. Time is of the essence: impact of delays on effectiveness of contact tracing for COVID-19 , 2020, medRxiv.
[11] L. Kucirka,et al. Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure , 2020, Annals of Internal Medicine.
[12] William L. Hamilton,et al. Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission , 2020, medRxiv.
[13] Periodic COVID-19 Testing in Emergency Department Staff , 2020, medRxiv.
[14] J. Moon,et al. COVID-19: PCR screening of asymptomatic health-care workers at London hospital , 2020, The Lancet.
[15] Hannah Fry,et al. Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study , 2020, The Lancet Infectious Diseases.
[16] Yongsheng Wu,et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study , 2020, The Lancet Infectious Diseases.
[17] Jose Lourenco,et al. Estimating false-negative detection rate of SARS-CoV-2 by RT-PCR , 2020, medRxiv.
[18] Y. Wen,et al. Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications , 2020, medRxiv.
[19] Yan Peng,et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients , 2020, Proceedings of the National Academy of Sciences.
[20] V. Demicheli,et al. The early phase of the COVID-19 outbreak in Lombardy, Italy , 2020, 2003.09320.
[21] Malik Peiris,et al. Viral dynamics in mild and severe cases of COVID-19 , 2020, The Lancet Infectious Diseases.
[22] Eric H. Y. Lau,et al. Temporal dynamics in viral shedding and transmissibility of COVID-19 , 2020, Nature Medicine.
[23] Ruiyun Li,et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2) , 2020, Science.
[24] Christl A. Donnelly,et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis , 2020, The Lancet Infectious Diseases.
[25] Lucie Abeler-Dörner,et al. Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing , 2020, Science.
[26] Hannah R. Meredith,et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application , 2020, Annals of Internal Medicine.
[27] Yongsheng Wu,et al. Epidemiology and Transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contacts , 2020, medRxiv.
[28] G. Chowell,et al. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[29] L. Meyers,et al. The serial interval of COVID-19 from publicly reported confirmed cases , 2020, medRxiv.
[30] W. Edmunds,et al. Incidence and risk factors for influenza-like-illness in the UK: online surveillance using Flusurvey , 2014, BMC Infectious Diseases.
[31] Ralph S. Baric,et al. A decade after SARS: strategies for controlling emerging coronaviruses , 2013, Nature Reviews Microbiology.
[32] N. Grassly,et al. Mathematical models of infectious disease transmission , 2008, Nature Reviews Microbiology.